Business Wire

Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items

Share

The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/

null

Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor)

These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the patented technology, it is expected to have a ripple effect on markets worth over $100 billion for finished goods and over $10 billion for packages in the lighting, automotive, and IT sectors.

Philips Lighting brand (currently Signify Group) is the world’s leading lighting company with 2023 annual revenue of approximately $7 billion. The Court ordered Conrad Electronic, the global distributor where these products are sold, to immediately cease the sale of certain products manufactured by affiliates of Philips Lighting brand, and also ordered the recall and destruction of infringing products distributed in the market since March 29, 2017. Additionally, the Court ruled that a fine of up to €250,000 per violation would be imposed for each non-compliance. This serves as a strong punitive measure to prevent the recurrence of such infringement activities. These court orders are applicable to all products with a CRI of 70 or higher, not just those manufactured by the affiliates of Philips Lighting brand. Particularly, by defeating the invalidation lawsuit filed by Philips Lighting, Seoul Semiconductor has strengthened the related patent technology.

For the past 30 years, Seoul Semiconductor has been pursuing its vision of "clean, healthy, and beautiful with light," striving to shift the paradigm from harmful artificial lighting to the light of nature. To achieve this, the company invests nearly $100 million annually, about 10% of its revenue, in research and development (R&D). As a result, Seoul Semiconductor holds an overwhelming number of over 18,000 optoelectronic patents in the LED industry and has collaborated with Mitsubishi Chemical Corporation (MCC) for years on joint research and development to improve CRI.

Chung Hoon Lee, Seoul’s founder and CEO said, “Infringement of intellectual property causes frustration among young entrepreneurs and innovative companies.” He added, “Our investment in preventing technology theft helps to create a fairer market and encourages young people and companies around the world to continue innovating, helping all of us contribute to a better world. This aligns with one of our company's three core missions: honor, trust, and contribution.”

About Seoul Semiconductor

Seoul Semiconductor is the world's third-largest global opto semiconductor (LED) company that has focused solely on LEDs for the past 30 years. Under the vision of "Make the world clean, healthy and beautiful with light" Seoul Semiconductor leads the new paradigm of light with world-first technologies in the fields of lighting, automotive, and IT (backlighting), while Seoul Viosys, a subsidiary, is at the forefront of MicroLED, UV, sensors, and Dacom.

Notable world-first technologies include the innovative no-wire LED "WICOP"; "SunLike," which replicates the full spectrum of natural sunlight; the high-voltage LED "Acrich"; the ultra-bright "nPola" LED, which is more than 10 times brighter than traditional LEDs; the RGB one-chip MicroLED "WICOP Pixel"; and the UV cleaning technology "Violeds."

Seoul Semiconductor holds an overwhelming 18,000 patents in the industry and has won over 100 patent litigations across eight countries in the past 20 years. Believing that the patent system offers hope to young people and serves as a stepping stone to a better world, the company actively engages in intellectual property protection activities. For more details, please visit our official websites (http://www.seoulsemicon.com/en, https://www.seoulviosys.com/en) and social media channels (LinkedIn).

About CRI (Color Rendering Index)

An indicator of how accurately a light source reproduces the colors of objects under natural sunlight. (For example, CRI 70: Designed so that the colors of 14 standard color samples match more than 70% of the colors seen under sunlight.)

View source version on businesswire.com: https://www.businesswire.com/news/home/20241225151382/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to

Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release

Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further

Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release

New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye